Abstract
A number of unique challenges are faced when attempting to estimate mortality attributable to illicit drugs. The hidden nature of illicit drug use creates difficulties in quantifying the prevalence of such use; identifying adverse health effects associated with exposure, and calculating the risk of these effects. The use of cohort studies of drug users allows the identification of causes of mortality associated with drug use and the determination of the risk of these causes. This risk estimate can then be used in conjunction with estimates of the prevalence of drug use to, extrapolate the burden of mortality. We identify a number of such studies and present some solutions to the major challenges faced when attempting to estimate the global burden of mortality attributable to illicit drug use.
Original language | English |
---|---|
Article number | N/A |
Pages (from-to) | 104-116 |
Number of pages | 13 |
Journal | European Addiction Research |
Volume | 7 |
Issue number | 3 |
DOIs | |
Publication status | Published - Aug 2001 |
Keywords
- epidemiology
- prevalence
- illicit drugs
- cohort study
- mortality
- attributable fraction
- NON-AIDS MORTALITY
- 22-YEAR FOLLOW-UP
- NEW-YORK-CITY
- METHADONE TREATMENT
- HEROIN-ADDICTS
- HIV-INFECTION
- POLYDRUG USE
- DEATH
- COHORT
- STOCKHOLM